Dichlorphenamide - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for dichlorphenamide and what is the scope of patent protection?

Dichlorphenamide is the generic ingredient in three branded drugs marketed by Xeris and Torrent, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for dichlorphenamide. Four suppliers are listed for this compound.

Summary for dichlorphenamide

US Patents:	0
Tradenames:	3
Applicants:	2
NDAs:	2
Drug Master File Entries:	3
Finished Product Suppliers / Packagers:	4
Raw Ingredient (Bulk) Api Vendors:	104
Clinical Trials:	2
Patent Applications:	5,829
What excipients (inactive ingredients) are in dichlorphenamide?	dichlorphenamide excipients list
DailyMed Link:	dichlorphenamide at DailyMed

Recent Clinical Trials for dichlorphenamide

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
National Institute of Neurological Disorders and Stroke (NINDS)	Phase 3
University of Rochester	Phase 3
Ohio State University	Phase 3

See all dichlorphenamide clinical trials

Pharmacology for dichlorphenamide

Drug Class	Carbonic Anhydrase Inhibitor
Mechanism of Action	Carbonic Anhydrase Inhibitors

Medical Subject Heading (MeSH) Categories for dichlorphenamide

Carbonic Anhydrase Inhibitors

US Patents and Regulatory Information for dichlorphenamide

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Torrent	ORMALVI	dichlorphenamide	TABLET;ORAL	215924-001	Dec 29, 2022	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Xeris	KEVEYIS	dichlorphenamide	TABLET;ORAL	011366-002	Aug 7, 2015	AB	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Xeris	DARANIDE	dichlorphenamide	TABLET;ORAL	011366-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.